A Novel Strategy to Rebalance Immunity in ITP – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia
In immune thrombocytopenia, tuning the enzymatic activity of CD38 restored regulatory T cell function through the deacetylase Sirt-1.
Working in patient cells and models, the authors show this approach rebalances immunity rather than broadly suppressing it, pointing to CD38 as a fresh therapeutic target that could explain durable responses in patients with ITP.”
Title: Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia
Authors: Mingfang Zhu, Haoyi Wang, Yitong Xu, Yubin Li, Wanru Wang, Lingjun Wang, Ruixue Wang, Ping Zhang, Ruting Wang, Junying Cao, Lin Wang, Yan Shi, Ming Hou, Yu Hou
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 11, 2026, 17:41Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
-
Sep 11, 2026, 17:29Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy
-
Sep 11, 2026, 16:38Jim Kaveney: Class I, Level A – Lifestyle is Now the Official Standard in AFib Care
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?